CV Sciences, Inc.
For the period ended Mar 31, 2025. Filed May 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 14, 2025
CVSIStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Exhibit Number · Exhibit Description · Form · File No. · Exhibit · Filing Date · Filed Herewith | |||||
|---|---|---|---|---|---|
| 2.1 | Agreement and Plan of Merger, dated as of July 25, 2013, by and between CannaVest Corp., a Texas corporation, and CannaVest Corp., a Delaware corporation | 10-Q | 000-54677 | 2.1 | August 13, 2013 |
| 2.2 | Agreement and Plan of Reorganization by and among CannaVEST Corp., CANNAVEST Merger Sub, Inc., CANNAVEST Acquisition LLC, CanX, Inc., and The Starwood Trust, as the Shareholder Representative | 8-K | 000-54677 | 2.1 | January 4, 2016 |
| 2.3 | Amendment No. 1 to the Agreement and Plan of Reorganization, dated as of March 16, 2017, by and among the Company, CANNAVEST Acquisition LLC, and the Starwood Trust, as the Shareholder Representative | 10-Q | 000-54677 | 10.4 | May 9, 2017 |
| 2.4 | Membership Interest Purchase Agreement, dated December 7, 2023, by and among the Company, Cultured Foods Sp. z.o.o., Brian McWhorter and Barbara McWhorter | 10-K | 000-54677 | 2.4 | March 29, 2024 |
| 2.5 | Membership Interest Purchase Agreement by and among CV Sciences, Inc., Elevated Softgels, LLC, Clayton J. Montgomery, Chris Fagan, Andrew Kester and Timothy McGreer, dated May 8, 2024 | 10-Q | 000-54677 | 2.5 | August 13, 2024 |
| 3.1 | Certificate of Incorporation of CannaVEST Corp., as filed on July 26, 2013. | 10-Q | 000-54677 | 3.1 | August 13, 2013 |
| 3.2 | Bylaws of CannaVEST Corp., dated as of June 26, 2013. | 10-Q | 000-54677 | 3.2 | August 13, 2013 |
| 3.3 | Certificate of Amendment to Certificate of Incorporation of CannaVest Corp., as filed on January 4, 2016. | 10-K | 000-54677 | 3.3 | April 14, 2016 |
| 3.4 | Certificate of Incorporation of the Company, as amended. | 10-Q | 000-54677 | 3.4 | May 16, 2016 |
| 3.5 | Amendment to the Bylaws of the Company, as amended. | 8-K | 000-54677 | 3.1 | March 22, 2017 |
| 3.6 | Bylaws of the Company, as amended. | 10-Q | 000-54677 | 3.6 | May 9, 2017 |
| 3.7 | Amendment to the Bylaws of the Company, as amended | 8-K | 000-54677 | 3.1 | June 14, 2021 |
| 3.8 | Certificate of Designation of Preference, Rights and Limitations of Convertible Preferred Stock. | 8-K | 000-54677 | 3.1 | April 1, 2022 |
| 3.9 | Certificate of Amendment to Certificate of Incorporation of CV Sciences, Inc., as filed on June 6, 2022 | 10-Q | 000-54677 | 3.9 | August 15, 2022 |
| 4.1 | CannaVEST Corp. Specimen Stock Certificate | 8-K | 000-54677 | 4.1 | July 31, 2013 |
| 4.2 | Form of Warrant, dated March 30, 2022 | 8-K | 000-54677 | 4.1 | April 1, 2022 |
| 4.3 | Form of Placement Agent Warrant, dated March 30, 2022 | 8-K | 000-54677 | 4.2 | April 1, 2022 |
| 10.1 | Note Purchase Agreement between the Company and Streeterville Capital, LLC dated July 3, 2024 | 8-K | 000-54677 | 10.1 | July 9, 2024 |
| 10.2 | Secured Promissory Note issued to Streeterville Capital, LLC dated July 3, 2024 | 8-K | 000-54677 | 10.2 | July 9, 2024 |
| 10.3 | Security Agreement between the Company and Streeterville Capital, LLC dated July 3, 2024 | 8-K | 000-54677 | 10.3 | July 9, 2024 | |
| 10.4 | Securities Purchase Agreement dated February 12, 2025 | 8-K | 000-54677 | 10.1 | February 20, 2025 | |
| 10.5 | Senior Secured Note Due August 12, 2026 | 8-K | 000-54677 | 10.2 | February 20, 2025 | |
| 10.6 | Security Agreement dated February 12, 2025 | 8-K | 000-54677 | 10.3 | February 20, 2025 | |
| 10.7 | Intellectual Property Security Agreement dated February 12, 2025 | 8-K | 000-54677 | 10.4 | February 20, 2025 | |
| 31.1* | Certification of the Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002. | X | ||||
| 31.2* | Certification of the Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002. | X | ||||
| 32.1* | Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 32.2* | Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 101 INS* | Inline XBRL Instance Document** | X | ||||
| 101 SCH* | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents** | X | ||||
| 104** | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101 attachments) | X | ||||
- Filed herewith.
** The XBRL related information in Exhibit 101 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.